Kite, Sangamo Partner on Gene-Edited Cell Therapies [News in Brief]

Firms will use zinc finger nuclease technology to make autologous and allogeneic CAR T-cell and other cellular treatments.

from Cancer via ola Kala on Inoreader http://ift.tt/2FkKIzl
via IFTTT